Navigation Links
Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council
Date:1/23/2008

Sims to Represent Association of Family Cord Blood Banks

LOS ANGELES, Jan. 23 /PRNewswire/ -- Family Cord Blood Services, a subsidiary of California Cryobank, today announced that its co-founder and medical director Charles A. Sims, MD, has been appointed to the Department of Health and Human Services' (HHS) Health Resources and Services Administration (HRSA) Advisory Council on Blood Stem Cell Transplantation (ACBSCT). Through his appointment, Dr. Sims will represent the Association of Family Cord Blood Banks (AFCBB), an organization representing the family cord blood banking industry that advocates matters of public policy, regulation and the development of industry standards by accrediting organizations.

Established to advise the Secretary of HHS and Administrator of HRSA on activities of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory (NCBI) Program, the ACBSCT is composed of 23 members serving as Special Government Employees. In addition to Dr. Sims, members include representatives of marrow donor centers and marrow transplant centers, recipients of bone marrow transplant and cord blood transplant, hematology and transfusion medicine researchers with expertise in adult blood stem cell, and members of the general public.

Dr. Sims is a board certified pathologist, laboratory director and has served as chief of pathology at Century City Hospital, Los Angeles. He has a broad understanding of cord blood banking and sperm bank development and operations. Prior to founding Family Cord Blood Services and California Cryobank, he served as laboratory director of a large national independent referral laboratory, and was the founder of Quantum Clinical Laboratories, Inc. Dr. Sims earned his medical degree from Loma Linda University and is certified by the American Board of Pathology in Anatomical and Clinical Pathology. He is also a member of numerous professional organizations including the American
'/>"/>

SOURCE Family Cord Blood Services
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
2. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
3. Physicians Practice, Loma Linda Partner to Improve Patient Care in Southern California
4. California Stem Cell Board Member Violates Conflict Rules; Should Resign From Committee, Consumer Group Says
5. California IVF Experts Tap Ethics Committee for Guidance
6. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
7. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
8. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
9. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
10. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
11. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...HAYWARD, Calif., Nov. 6 Intarcia T...y on its ITCA 650 (DUROS® continuous delivery... diabetes at the Ninth Annual Diabetes Technology .../www.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO...natide Via ITCA 650 Lowers Plasma Glucose, HbA1c a...
(Date:11/5/2009)...GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCall/ -...s financial results for the third quarter ended Se....6 million ($0.04 per share) for the three months ... $6.8 million ($0.08 per share) in the comparable ...er 30, 2009, GenVec,s net loss was $14.1 million (...
(Date:11/5/2009)...SAN DIEGO, Nov. 5 Imagen...oday that William Spencer, President and CEO of Im...t the 2nd annual LD MICRO Conference on Thursday, ...n Los Angeles. ,, About LD MICRO ,, LD MICRO...ses on finding undervalued companies in the micro-...
(Date:11/5/2009)...OMAHA, Neb., Nov. 5 Tran...nounced financial results for the quarter ended Se...are presented in the tables that follow. ,, Th... loss of $366,000 or $0.01 per share for the third...,000 or $0.01 per share for the third quarter of 2...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ugal, December 8 , - Data Highlight The Eff...ty of Life and Depressive Symptoms With Zebinix(TM...from three phase III studies presented today at th...e, USA, show that,Zebinix(TM)(1) (eslicarbazepine ... significantly reduced the frequency of partial se...
... PHILADELPHIA, Dec. 8 GlaxoSmithKline,(LSE/NYSE: ...reviously announced,tender offer to purchase all o...bs Technologies, Inc. (Nasdaq: GNLB ), for $1.30...equired withholding taxes, until 12:00 midnight,ES...offer is further extended.,The tender offer was or...
...ation announces its focus on new Rapid-Fill ASF co...(PACT) products at the 2008 American Society of He...and Exhibition beginning today at the Orange Count...WOOD, Colo., Dec. 8 Baxa Corporation is featuring... Productivity and Compliance Tools (PACT), Exacta-...
Other Biology Technology:Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 2Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 3Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 4Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 5Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 6Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 7GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc. 2Baxa Features Rapid-Fill(TM) Colored Labels, PACT(TM) Products, Exacta-Mix(TM) 2400 Compounders and Abacus(TM) Software at the ASHP Mid-Year Clinical Meeting 2Baxa Features Rapid-Fill(TM) Colored Labels, PACT(TM) Products, Exacta-Mix(TM) 2400 Compounders and Abacus(TM) Software at the ASHP Mid-Year Clinical Meeting 3
(Date:11/8/2009)... WEST LAFAYETTE, Ind. - Researchers at Purdue Univ...g damaged nerve fibers in spinal cord injuries usi...ood shortly after an accident. , The synthetic "...t 60 nanometers in diameter, or roughly 100 times ... Researchers have been studying how to deliver dru...
(Date:11/6/2009)...ee-dwelling ants generally live in harmony with th... when they run out of space in their trees of choi...ees. , The research, published in the November i... document that ants bore into live trees, and it r...between ants and plants. , Ants and certain spec...
(Date:11/5/2009)...nt State University has been awarded a training gr...ience Foundation under its Integrative Graduation ...his is the first IGERT grant to be awarded to Kent...can Recovery and Reinvestment Act of 2009, runs th...hat focuses on environment aquatic resource sensin...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2American Airlines Employees Raise 241 Million for American Cancer Society 56600 1American Airlines Employees Raise 241 Million for American Cancer Society 56600 2American Airlines Employees Raise 241 Million for American Cancer Society 56600 3Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 1Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9
... Using a "clot buster" drug normally reserved for ... room doctors were able to double the number of pa...his sudden loss of heart function occurs in more t... 93 percent of them die. , "Clot-busting agents sh...tastrophic loss of heart function," said William P...
... It turns out that the sea slug isn,t really that ...study of this charismatic orange creature,s behavi...ril 2006 issue of The Biological Bulletin. , The ...nown as Tritonia diomedea, a nudibranch mollusc sp...mportant in laboratory studies of the how the brai...
... Acid rain, the environmental consequence of burni...s, has altered soils and reduced the number of sug... to a new study led by Cornell University research...aluable tree species in the eastern United States ...st-attracting fall colors. , The study, whose l...
Other Biology News:Clot-busting drug helps revive cardiac arrest patients 2The secret lives of sea slugs 2Acid rain causing decline in sugar maples, say researchers 2Acid rain causing decline in sugar maples, say researchers 3
Goat Anti-Human RELT / TNFRSF19L Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-HOXD3 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Goat Anti-Mouse NOV / CCN3 Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human SNAPAP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: